0000899243-22-029606.txt : 20220824
0000899243-22-029606.hdr.sgml : 20220824
20220824160550
ACCESSION NUMBER: 0000899243-22-029606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220822
FILED AS OF DATE: 20220824
DATE AS OF CHANGE: 20220824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ceesay Abraham
CENTRAL INDEX KEY: 0001722140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39311
FILM NUMBER: 221191576
MAIL ADDRESS:
STREET 1: C/O SCPHARMACEUTICALS, INC.
STREET 2: 2400 DISTRICT AVENUE SUITE 310
CITY: BURLINGTON
STATE: MA
ZIP: 01830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001805387
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 JACOBS STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 844-304-2048
MAIL ADDRESS:
STREET 1: 222 JACOBS STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II
DATE OF NAME CHANGE: 20200303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-22
0
0001805387
Cerevel Therapeutics Holdings, Inc.
CERE
0001722140
Ceesay Abraham
C/O CEREVEL THERAPEUTICS HOLDINGS, INC.
222 JACOBS STREET, SUITE 200
CAMBRIDGE
MA
02141
0
1
0
0
President
Common Stock
2022-08-22
4
M
0
9605
13.17
A
9605
D
Common Stock
2022-08-22
4
S
0
9605
32.50
D
0
D
Stock Option (Right to Buy)
13.17
2022-08-22
4
M
0
9605
0.00
D
2031-06-01
Common Stock
9605
384219
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 17, 2022 adopted by the Reporting Person.
25% of the shares subject to this option vested and became exercisable on June 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
/s/ Mark Bodenrader, as Attorney-in-Fact
2022-08-24